As previous studies’ findings suggest that Ets-1 downregulation in vitiligo-affected skin may contribute to the depigmented phenotype observed in vitiligo [13, 14], we hypothesize the Ets-1 gene-deficient mice could serve as a suitable model for studying vitiligo pathogenesis and developing therapeutics for skin depigmentation disorders. This evidence concerns the gene ETS1 and vitiligo.